Market Closed -
Other stock markets
|
After market 21:00:02 | |||
210.8 EUR | -0.75% | 210.1 | -0.33% |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- With an expected P/E ratio at 32.11 and 28.46 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- With an enterprise value anticipated at 3.91 times the sales for the current fiscal year, the company turns out to be overvalued.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-3.23% | 66.14B | - | ||
-5.50% | 178B | C+ | ||
-5.79% | 98.95B | C | ||
-8.38% | 44.11B | B- | ||
+8.42% | 43.82B | B- | ||
+10.10% | 42.74B | B+ | ||
+10.97% | 28.92B | B | ||
+18.89% | 25.06B | A- | ||
-8.39% | 23.38B | A- | ||
-11.25% | 21.93B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BDX Stock
- BOX Stock
- Ratings Becton, Dickinson and Company